Cross-institution positioning
Aug 7, 2026Accumulation leaning. 2 accumulating, 2 exited across 4 comparable institutions.
Source: Schedule 13 researchSee how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Accumulation leaning. 2 accumulating, 2 exited across 4 comparable institutions.
Source: Schedule 13 research2 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsOver the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 1 sale by 1 reporting owner. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/53 non-amendment material events in the last 90 days; 2 capital-related filing/events (2 equity-related, 0 debt-related); Latest classified evidence: Material definitive agreement. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue -17.5% YoY; Net income -379.8% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 5% through its reported 52-week range; -70.1% over one year.
Source: Stored historical price seriesFiled Aug 7, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | Scanlan Jacqueline | FTax/price withholding or payment | Common Stock | 5.1K | $9.58 | Direct | Sep 30, 2026 |
| Sep 9, 2026 | Pfeiffer Nicholas | SOpen-market or private sale | Common Stock | 1.3K | $12.78 | Direct | Sep 10, 2026 |
| Jul 16, 2026 | Verduin Patricia | AGrant, award, or other acquisition | Common Stock | 50 | $0.00 | Direct | Jul 17, 2026 |
| Jul 16, 2026 | MERKT STEVEN T | AGrant, award, or other acquisition | Common Stock | 41 | $0.00 | Direct | Jul 17, 2026 |
| Jul 16, 2026 | Raines John Mitchell | AGrant, award, or other acquisition | Common Stock | 48 | $0.00 | Direct | Jul 17, 2026 |
| Jul 16, 2026 | BARRY MICHAEL F | AGrant, award, or other acquisition | Common Stock | 11 | $0.00 | Direct | Jul 17, 2026 |
| Jul 16, 2026 | Johnson KLynne | AGrant, award, or other acquisition | Common Stock | 184 | $0.00 | Direct | Jul 17, 2026 |
| Jul 16, 2026 | Fortmann Kathy Lynn | AGrant, award, or other acquisition | Common Stock | 101 | $0.00 | Direct | Jul 17, 2026 |
| Jul 16, 2026 | DAVIDSON CAROL ANTHONY | AGrant, award, or other acquisition | Common Stock | 83 | $0.00 | Direct | Jul 17, 2026 |
| Jul 16, 2026 | CORDEIRO EDUARDO E | AGrant, award, or other acquisition | Common Stock | 131 | $0.00 | Direct | Jul 17, 2026 |
| Jul 16, 2026 | BRONDEAU PIERRE R | AGrant, award, or other acquisition | Common Stock | 44 | $0.00 | Direct | Jul 17, 2026 |
| Jun 11, 2026 | BRONDEAU PIERRE R | FTax/price withholding or payment | Common Stock | 34.2K | $10.80 | Direct | Jun 15, 2026 |
| Apr 28, 2026 | Verduin Patricia | AGrant, award, or other acquisition | Common Stock | 9.2K | $0.00 | Direct | Apr 30, 2026 |
| Apr 28, 2026 | Raines John Mitchell | AGrant, award, or other acquisition | Common Stock | 9.2K | $0.00 | Direct | Apr 30, 2026 |
| Apr 28, 2026 | Pallash Robert C | FTax/price withholding or payment | Common Stock | 18.8K | $15.56 | Direct | Apr 30, 2026 |
| Apr 28, 2026 | Oevrum Margareth | FTax/price withholding or payment | Common Stock | 680 | $15.56 | Direct | Apr 30, 2026 |
| Apr 28, 2026 | MERKT STEVEN T | AGrant, award, or other acquisition | Common Stock | 9.2K | $0.00 | Direct | Apr 30, 2026 |
| Apr 28, 2026 | Johnson KLynne | AGrant, award, or other acquisition | Common Stock | 9.2K | $0.00 | Direct | Apr 30, 2026 |
| Apr 28, 2026 | GREER C SCOTT | FTax/price withholding or payment | Common Stock | 1.0K | $15.56 | Direct | Apr 30, 2026 |
| Apr 28, 2026 | Fortmann Kathy Lynn | AGrant, award, or other acquisition | Common Stock | 9.2K | $0.00 | Direct | Apr 30, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Sep 23, 2026 | 8-K | 1.01, 3.02, 7.01, 9.01 | Material definitive agreement; Unregistered sale of equity securities; Regulation FD disclosure; Financial statements / exhibits | Equity | Filing |
| Jul 29, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jul 1, 2026 | 8-K | 1.01, 3.02, 7.01, 9.01 | Material definitive agreement; Unregistered sale of equity securities; Regulation FD disclosure; Financial statements / exhibits | Equity | Filing |
| Jun 23, 2026 | 8-K | 1.01, 2.03, 9.01 | Material definitive agreement; New direct financial obligation; Financial statements / exhibits | Debt | Filing |
| Jun 23, 2026 | 8-K | 1.01, 9.01 | Material definitive agreement; Financial statements / exhibits | — | Filing |
| Jun 5, 2026 | 8-K | 1.01, 2.03, 9.01 | Material definitive agreement; New direct financial obligation; Financial statements / exhibits | Debt | Filing |
| May 21, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| May 19, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Apr 29, 2026 | 8-K | 5.02, 5.03, 5.07, 9.01 | Director or executive change; Charter or bylaw change; Shareholder vote results; Financial statements / exhibits | — | Filing |
| Apr 29, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Apr 20, 2026 | 8-K | 1.01, 2.03, 9.01 | Material definitive agreement; New direct financial obligation; Financial statements / exhibits | Debt | Filing |
| Feb 4, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 30, 2026 | $867.1M | -17.5% |
| Ended Mar 31, 2026 | $758.6M | -4.1% |
| Ended Dec 31, 2025 | $1.1B | -11.5% |
| Ended Sep 30, 2025 | $542.2M | -49.1% |
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | $3.5B | -18.3% |
| Ended Dec 31, 2024 | $4.2B | -5.4% |
| Ended Dec 31, 2023 | $4.5B | -22.7% |
| Ended Dec 31, 2022 | $5.8B | +15.0% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Capital Management CIK0002100119 | Jun 30, 2026 quarter end Aug 13, 2026 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 5.8M | $8.35 | |||
| State Street CIK0000093751 | Jun 30, 2026 observed Aug 7, 2026 filed · 38d Initial Schedule 13G | Initial Schedule 13G | 6.5M +1.8M | 5.20% -6.80 pts | $11.50 | $10.59 | $8.35 |
| BlackRock CIK0002012383 | Jun 30, 2026 observed Jul 28, 2026 filed · 28d Schedule 13G amendment | Reported accumulation | 19.3M +4.2M | 15.50% +3.40 pts | $11.50 | $10.94 | $8.35 |
Compare FMC with other securities showing similar institutional activity or recent accumulation across several tracked institutions.